Stay updated on Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.

Latest updates to the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page
- Check5 days agoChange DetectedAn NIH announcement banner says federal agencies are transitioning from “Artificial Intelligence” to “Super Intelligence” terminology and links to updates and FAQs.SummaryDifference1%

- Check12 days agoChange DetectedThe footer now identifies the site as revision v3.7.2 instead of v3.7.1. The page continues to show a 403 error rather than the study record.SummaryDifference0.2%

- Check19 days agoChange DetectedThe footer revision label changes from v3.7.0 to v3.7.1 while the study page remains a 403 error page.SummaryDifference0.2%

- Check40 days agoChange DetectedThe page now shows a 403 Forbidden error with limited navigation, replacing the normal study content. The update appears to be a site wrapper change rather than changes to the study data itself.SummaryDifference20%

- Check61 days agoChange DetectedThe site shows a new Revision: v3.6.6, replacing the previous Revision: v3.6.5. This reflects an updated build/version of the page.SummaryDifference0.1%

- Check82 days agoChange DetectedRevision updated from v3.6.4 to v3.6.5, indicating a platform/internal update. There is no alteration to the study content, eligibility criteria, or results.SummaryDifference0.0%

Stay in the know with updates to Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Mets Melanoma: (C11-AMT) PET Clinical Trial page.